<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract Yellow fever is a potentially fatal, mosquito-borne" exact="viral disease" post="that appears to be experiencing a resurgence in endemic"/>
 <result pre="to areas in Asia with ecological conditions that can sustain" exact="yellow fever" post="virus transmission. In this article, we provide a broad"/>
 <result pre="transmission. In this article, we provide a broad overview of" exact="yellow fever" post="burden of disease, natural history, treatment, vaccine, prevention and"/>
 <result pre="and control initiatives, and vaccine and therapeutic agent development efforts." exact="yellow fever" post="vaccine flavivirus mosquito-borne acute febrile illness 1. Background Yellow"/>
 <result pre="caused by a member of the family Flaviviridae, genus Flavivirus," exact="yellow fever" post="virus (YFV) [1]. The disease is endemic in equatorial"/>
 <result pre="epigastric pain, jaundice, oliguria, and hemorrhagic manifestations. Patients may develop" exact="metabolic acidosis" post="and organ impairment involving the liver, pancreas, kidneys and"/>
 <result pre="disease require intensive care management to prevent and treat shock," exact="metabolic acidosis," post="hypoglycemia, stress-induced gastritis, bleeding, hepatic dysfunction, renal failure, and"/>
 <result pre="trials. For example, sofosbuvir, a uridine analog used to treat" exact="hepatitis" post="C, has shown antiviral activity against YFV in cell-based"/>
 <result pre="YF vaccine is comparable to the rate of vaccine-associated paralytic" exact="poliomyelitis" post="with oral polio vaccine [97,98]. In addition, because YF"/>
 <result pre="support sustained replication of the 17D strain [108]. Encephalitis and" exact="meningoencephalitis" post="associated with 17D vaccine administration in infants was first"/>
 <result pre="to direct viral invasion of the central nervous system (e.g.," exact="encephalitis" post="and meningitis) but also autoimmune-mediated demyelination and neuropathy including"/>
 <result pre="system (e.g., encephalitis and meningitis) but also autoimmune-mediated demyelination and" exact="neuropathy" post="including Guillain-Barre´ syndrome, acute disseminated encephalomyelitis, myelitis, and cranial"/>
 <result pre="meningitis) but also autoimmune-mediated demyelination and neuropathy including Guillain-Barre´ syndrome," exact="acute disseminated encephalomyelitis," post="myelitis, and cranial neuropathies. YEL-AND typically occurs 2-56 days"/>
 <result pre="≥60 years old [110,111,112]. In 2009, the first case of" exact="encephalitis" post="in an infant was confirmed to be caused by"/>
 <result pre="[133]. 10. Summary Points YF is a potentially fatal, mosquito-borne" exact="viral disease" post="that appears to be experiencing a resurgence in endemic"/>
 <result pre="Virol.20193410410910.1016/j.coviro.2019.01.00130743191 2.HamletA.JeanK.PereaW.YactayoS.BieyJ.Van KerkhoveM.FergusonN.GarskeT.The seasonal influence of climate and environment on" exact="yellow fever" post="transmission across AfricaPLoS Negl. Trop. Dis.201812e000628410.1371/journal.pntd.000628429543798 3.WeetmanD.KamgangB.BadoloA.MoyesC.L.ShearerF.M.CoulibalyM.PintoJ.LambrechtsL.McCallP.J.Aedes Mosquitoes and"/>
 <result pre="Public Health20181522010.3390/ijerph1502022029382107 4.HamrickP.N.AldighieriS.MachadoG.LeonelD.G.VilcaL.M.UrionaS.SchneiderM.C.Geographic patterns and environmental factors associated with human" exact="yellow fever" post="presence in the AmericasPLoS Negl. Trop. Dis.20171110.1371/journal.pntd.0005897 5.AbreuF.V.S.RibeiroI.P.Ferreira-de-BritoA.SantosA.MirandaR.M.BonellyI.S.NevesM.BersotM.I.SantosT.P.D.GomesM.Q.et al.Haemagogus"/>
 <result pre="and Haemagogus janthinomys are the primary vectors in the major" exact="yellow fever" post="outbreak in Brazil, 2016–2018Emerg. Microbes Infect.2019821823110.1080/22221751.2019.156818030866775 6.BarrettA.D.T.The reemergence of"/>
 <result pre="of yellow feverScience201836184784810.1126/science.aau822530139914 7.WamalaJ.F.MalimboM.OkotC.L.Atai-OmorutoA.D.TenywaE.MillerJ.R.BalinandiS.ShoemakerT.OyooC.OmonyE.O.et al.Epidemiological and laboratory characterization of a" exact="yellow fever" post="outbreak in northern Uganda, October 2010–January 2011Int. J. Infect."/>
 <result pre="Uganda, October 2010–January 2011Int. J. Infect. Dis.201216e536e54210.1016/j.ijid.2012.03.00422575876 8.KwagonzaL.MasiiraB.Kyobe-BosaH.KadoberaD.AtuheireE.B.LubwamaB.KagiritaA.KatushabeE.KayiwaJ.T.LutwamaJ.J.et al.Outbreak of" exact="yellow fever" post="in central and southwestern Uganda, February-may 2016BMC Infect. Dis.20181810.1186/s12879-018-3440-y"/>
 <result pre="and southwestern Uganda, February-may 2016BMC Infect. Dis.20181810.1186/s12879-018-3440-y 9.LilayA.AsameneN.BekeleA.MengeshaM.WendabekuM.TarekeI.GirmayA.WuletawY.AdossaA.BaY.et al.Reemergence of" exact="yellow fever" post="in Ethiopia after 50 years, 2013: Epidemiological and entomological"/>
 <result pre="Yellow Fever in Angola, 2015–2016Emerg. Infect. Dis.2016221854185510.3201/eid2210.16081827536787 11.KraemerM.U.G.FariaN.R.ReinerR.C.Jr.GoldingN.NikolayB.StasseS.JohanssonM.A.SaljeH.FayeO.WintG.R.W.et al.Spread of" exact="yellow fever" post="virus outbreak in Angola and the Democratic Republic of"/>
 <result pre="Epidemiological Report, Week 52Nigeria Centre for Disease ControlAbuja, Nigeria2018 13.IngelbeenB.WeregemereN.A.NoelH.TshapendaG.P.MossokoM.NsioJ.RonsseA.Ahuka-MundekeS.CohuetS.KebelaB.I.Urban" exact="yellow fever" post="outbreak-Democratic Republic of the Congo, 2016: Towards more rapid"/>
 <result pre="China from Angola, March 2016Emerg. Infect. Dis.2016221317131810.3201/eid2207.16046927314417 16.CuiS.J.PanY.LyuY.N.LiangZ.C.LiJ.SunY.L.DouX.F.TianL.L.HuoD.ChenL.J.et al.Detection of" exact="yellow fever" post="virus genomes from four imported cases in ChinaInt. J."/>
 <result pre="Salud Pública201943e2910.26633/RPSP.2019.2931093253 21.GossnerC.M.HaussigJ.M.de Bellegarde de Saint LaryC.Kaasik AaslavK.SchlagenhaufP.SudreB.Increased risk of" exact="yellow fever" post="infections among unvaccinated European travellers due to ongoing outbreak"/>
 <result pre="Brazilian Regions from 2015 to 2018Front. Microbiol.201910107910.3389/fmicb.2019.0107931178835 23.AmakuM.CoutinhoF.A.MassadE.Why dengue and" exact="yellow fever" post="coexist in some areas of the world and not"/>
 <result pre="populations from dengue incidence data: Implications for the risk of" exact="yellow fever" post="outbreaksInfect. Dis. Model.2017244145410.1016/j.idm.2017.12.00130137722 26.DorigattiI.HamletA.AguasR.CattarinoL.CoriA.DonnellyC.A.GarskeT.ImaiN.FergusonN.M.International risk of yellow fever spread"/>
 <result pre="risk of yellow fever outbreaksInfect. Dis. Model.2017244145410.1016/j.idm.2017.12.00130137722 26.DorigattiI.HamletA.AguasR.CattarinoL.CoriA.DonnellyC.A.GarskeT.ImaiN.FergusonN.M.International risk of" exact="yellow fever" post="spread from the ongoing outbreak in Brazil, December 2016"/>
 <result pre="Wkly. Rep.20186734034110.15585/mmwr.mm6711e129565840 28.BrentS.E.WattsA.CetronM.GermanM.KraemerM.U.BogochI.I.BradyO.J.HayS.I.CreatoreM.I.KhanK.International travel between global urban centres vulnerable to" exact="yellow fever" post="transmissionBull. World Health Organ.201896343B354B10.2471/BLT.17.20565829875519 29.VasconcelosP.F.Yellow fever in Brazil: Thoughts"/>
 <result pre="Vaccine Shortage - United States, 2016–2017Morb. Mortal. Wkly. Rep.20176645745910.15585/mmwr.mm6617e2 32.RoukensA.H.E.VisserL.G.Fractional-dose" exact="yellow fever" post="vaccination: An expert reviewJ. Travel Med.20192610.1093/jtm/taz024 33.collab: World Health"/>
 <result pre="vaccination: An expert reviewJ. Travel Med.20192610.1093/jtm/taz024 33.collab: World Health OrganizationEliminate" exact="yellow fever" post="epidemics (EYE): A global strategy, 2017–2026Wkly. Epidemiol. Rec.201716193204 34.collab:"/>
 <result pre="Trop. Med. Hyg.20108318318810.4269/ajtmh.2010.09-078220595499 38.JohanssonM.A.VasconcelosP.F.StaplesJ.E.The whole iceberg: Estimating the incidence of" exact="yellow fever" post="virus infection from the number of severe casesTrans. R."/>
 <result pre="studyLancet Infect. Dis.20191975075810.1016/S1473-3099(19)30125-231104909 40.TuboiS.H.CostaZ.G.da Costa VasconcelosP.F.HatchD.Clinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: Analysis of reported cases 1998-2002Trans. R. Soc."/>
 <result pre="viral load) are prognostic factors for the evolution of severe" exact="yellow fever" post="casesMemórias do Instituto Oswaldo Cruz2019114e19003310.1590/0074-0276019003331116245 42.Duarte-NetoA.N.CunhaM.D.P.MarcilioI.SongA.T.W.de MartinoR.B.HoY.L.PourS.Z.DolhnikoffM.SaldivaP.H.N.DuarteM.I.S.et al.Yellow fever"/>
 <result pre="feverTrans. R. Soc. Trop. Med. Hyg.19817528228610.1016/0035-9203(81)90335-77029803 45.MiyajiK.T.Avelino-SilvaV.I.SimoesM.FreireM.D.MedeirosC.R.BragaP.E.NevesM.A.LopesM.H.KallasE.G.SartoriA.M.Prevalence and titers of" exact="yellow fever" post="virus neutralizing antibodies in previously vaccinated adultsRev. Inst. Med."/>
 <result pre="against Yellow FeverJ. Exp. Med.19315453355510.1084/jem.54.4.53319869938 48.BauerJ.H.HudsonN.P.Duration of immunity in human" exact="yellow fever" post="as shown by protective power of serumJ. Prev. Med.19304177178"/>
 <result pre="protective power of serumJ. Prev. Med.19304177178 49.BlakeL.E.Garcia-BlancoM.A.Human genetic variation and" exact="yellow fever" post="mortality during 19th century U.S. epidemicsmBio20145e01253-1410.1128/mBio.01253-1424895309 50.OliveiraR.A.de Oliveira-FilhoE.F.FernandesA.I.BritoC.A.MarquesE.T.TenorioM.C.GilL.H.Previous dengue"/>
 <result pre="Glob. Infect. Dis.2009111111610.4103/0974-777X.5625720300401 52.MonathT.P.Treatment of yellow feverAntivir. Res.20087811612410.1016/j.antiviral.2007.10.00918061688 53.HoY.L.JoelsonsD.LeiteG.F.C.MalbouissonL.M.S.SongA.T.W.PerondiB.AndradeL.C.PintoL.F.D’AlbuquerqueL.A.C.SeguradoA.A.C.et al.Severe" exact="yellow fever" post="in Brazil: Clinical characteristics and managementJ. Travel Med.20192610.1093/jtm/taz040 54.ZandiK.AmblardF.AmichaiS.BassitL.TaoS.JiangY.ZhouL.Ollinger"/>
 <result pre="nucleoside analogue BCX4430Nature201450840240510.1038/nature1302724590073 59.JulanderJ.G.BantiaS.TaubenheimB.R.MinningD.M.KotianP.MorreyJ.D.SmeeD.F.SheridanW.P.BabuY.S.BCX4430, a novel nucleoside analog, effectively treats" exact="yellow fever" post="in a Hamster modelAntimicrob. Agents Chemother.2014586607661410.1128/AAC.03368-1425155605 60.collab: ClinicalTrials.govA Study"/>
 <result pre="for International TravelBrunetteG.W.NemhauserJ.B.Oxford University PressOxford, UK2019 70.KaulR.B.EvansM.V.MurdockC.C.DrakeJ.M.Spatio-temporal spillover risk of" exact="yellow fever" post="in BrazilParasites Vectors20181148810.1186/s13071-018-3063-630157908 71.MorenoE.S.SpinolaR.TenganC.H.BrasilR.A.SicilianoM.M.CoimbraT.L.SilveiraV.R.RoccoI.M.BisordiI.SouzaR.P.et al.Yellow fever epizootics in non-human"/>
 <result pre="77.ShearerF.M.LongbottomJ.BrowneA.J.PigottD.M.BradyO.J.KraemerM.U.G.MarinhoF.YactayoS.de AraujoV.E.M.da NobregaA.A.et al.Existing and potential infection risk zones of" exact="yellow fever" post="worldwide: A modelling analysisLancet Glob. Health20186e270e27810.1016/S2214-109X(18)30024-X29398634 78.HamletA.JeanK.YactayoS.BenzlerJ.CibrelusL.FergusonN.GarskeT.POLICI: A web"/>
 <result pre="Glob. Health20186e270e27810.1016/S2214-109X(18)30024-X29398634 78.HamletA.JeanK.YactayoS.BenzlerJ.CibrelusL.FergusonN.GarskeT.POLICI: A web application for visualising and extracting" exact="yellow fever" post="vaccination coverage in AfricaVaccine2019371384138810.1016/j.vaccine.2019.01.07430770224 79.PolonskyJ.A.BaidjoeA.KamvarZ.N.CoriA.DurskiK.EdmundsW.J.EggoR.M.FunkS.KaiserL.KeatingP.et al.Outbreak analytics: A developing"/>
 <result pre="emerging pathogensPhilos. Trans. R. Soc. B201937410.1098/rstb.2018.027631104603 80.KraemerM.U.G.CummingsD.A.T.FunkS.ReinerR.C.FariaN.R.PybusO.G.CauchemezS.Reconstruction and prediction of" exact="viral disease" post="epidemicsEpidemiol. Infect.201914710.1017/S095026881800288130394230 81.ChildsM.L.NovaN.ColvinJ.MordecaiE.A.Mosquito and primate ecology predict human risk"/>
 <result pre="epidemicsEpidemiol. Infect.201914710.1017/S095026881800288130394230 81.ChildsM.L.NovaN.ColvinJ.MordecaiE.A.Mosquito and primate ecology predict human risk of" exact="yellow fever" post="virus spillover in BrazilPhilos. Trans. R. Soc. Lond. B"/>
 <result pre="Virus to Cultivation in VitroJ. Exp. Med.19376580180810.1084/jem.65.6.80119870635 83.StokesA.BauerJ.H.HudsonX.P.Experimental transmission of" exact="yellow fever" post="to laboratory animalsAm. J. Trop. Med.1928810316410.4269/ajtmh.1928.s1-8.103 84.TheilerM.SmithH.H.The Effect of"/>
 <result pre="of Vaccine Supply and DemandN. Engl. J. Med.201637530130310.1056/NEJMp160699727276108 87.ShearerF.M.MoyesC.L.PigottD.M.BradyO.J.MarinhoF.DeshpandeA.LongbottomJ.BrowneA.J.KraemerM.U.G.O’ReillyK.M.et al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: An adjusted retrospective"/>
 <result pre="of Imported Stamaril VaccineMorb. Mortal. Wkly. Rep.20176678010.15585/mmwr.mm6629a4 89.WuJ.T.PeakC.M.LeungG.M.LipsitchM.Fractional dosing of" exact="yellow fever" post="vaccine to extend supply: A modelling studyLancet20163882904291110.1016/S0140-6736(16)31838-427837923 90.collab: World"/>
 <result pre="of fractional doses—June 2017, addendum to vaccines and vaccination against" exact="yellow fever" post="WHO: Position paper—June 2013Vaccine2017355751575210.1016/j.vaccine.2017.06.08728689653 91.ChenL.H.HamerD.H.Vaccination Challenges in Confronting the"/>
 <result pre="Fever Outbreak—Final ReportN. Engl. J. Med.201938144445410.1056/NEJMoa171043029443626 94.LindseyN.P.RabeI.B.MillerE.R.FischerM.StaplesJ.E.Adverse event reports following" exact="yellow fever" post="vaccination, 2007–2013J. Travel Med.20162310.1093/jtm/taw045 95.LindseyN.P.SchroederB.A.MillerE.R.BraunM.M.HinckleyA.F.MaranoN.SladeB.A.BarnettE.D.BrunetteG.W.HoranK.et al.Adverse event reports following"/>
 <result pre="fever vaccination, 2007–2013J. Travel Med.20162310.1093/jtm/taw045 95.LindseyN.P.SchroederB.A.MillerE.R.BraunM.M.HinckleyA.F.MaranoN.SladeB.A.BarnettE.D.BrunetteG.W.HoranK.et al.Adverse event reports following" exact="yellow fever" post="vaccinationVaccine2008266077608210.1016/j.vaccine.2008.09.00918809449 96.MonathT.P.Review of the risks and benefits of yellow"/>
 <result pre="yellow fever vaccinationVaccine2008266077608210.1016/j.vaccine.2008.09.00918809449 96.MonathT.P.Review of the risks and benefits of" exact="yellow fever" post="vaccination including some new analysesExpert Rev. Vaccines20121142744810.1586/erv.12.622551029 97.HayesE.B.Is it"/>
 <result pre="new analysesExpert Rev. Vaccines20121142744810.1586/erv.12.622551029 97.HayesE.B.Is it time for a new" exact="yellow fever" post="vaccine?Vaccine2010288073807610.1016/j.vaccine.2010.10.01520971115 98.AmannaI.J.SlifkaM.K.Questions regarding the safety and duration of immunity"/>
 <result pre="98.AmannaI.J.SlifkaM.K.Questions regarding the safety and duration of immunity following live" exact="yellow fever" post="vaccinationExpert Rev. Vaccines2016151519153310.1080/14760584.2016.119825927267203 99.collab: Centers for Disease Control and"/>
 <result pre="IFNAR1 deficiency in otherwise healthy patients with adverse reaction to" exact="measles" post="and yellow fever live vaccinesJ. Exp. Med.20192162057207010.1084/jem.2018229531270247 102.DeSilvaM.SharmaA.StaplesE.ArndtB.ShiehW.J.ShamesJ.CieslakP.Notes from"/>
 <result pre="in otherwise healthy patients with adverse reaction to measles and" exact="yellow fever" post="live vaccinesJ. Exp. Med.20192162057207010.1084/jem.2018229531270247 102.DeSilvaM.SharmaA.StaplesE.ArndtB.ShiehW.J.ShamesJ.CieslakP.Notes from the field: Fatal"/>
 <result pre="fever live vaccinesJ. Exp. Med.20192162057207010.1084/jem.2018229531270247 102.DeSilvaM.SharmaA.StaplesE.ArndtB.ShiehW.J.ShamesJ.CieslakP.Notes from the field: Fatal" exact="yellow fever" post="vaccine-associated viscerotropic disease—Oregon, September 2014Morb. Mortal. Wkly. Rep.201564279281 103.SeligmanS.J.Risk"/>
 <result pre="viscerotropic disease—Oregon, September 2014Morb. Mortal. Wkly. Rep.201564279281 103.SeligmanS.J.Risk groups for" exact="yellow fever" post="vaccine-associated viscerotropic disease (YEL-AVD)Vaccine2014325769577510.1016/j.vaccine.2014.08.05125192973 104.HayesE.B.Acute viscerotropic disease following vaccination"/>
 <result pre="subjects have a delayed antibody response and prolonged viraemia following" exact="yellow fever" post="vaccination: A prospective controlled cohort studyPLoS ONE20116e2775310.1371/journal.pone.002775322163273 106.MeierK.C.GardnerC.L.KhoretonenkoM.V.KlimstraW.B.RymanK.D.A mouse"/>
 <result pre="ONE20116e2775310.1371/journal.pone.002775322163273 106.MeierK.C.GardnerC.L.KhoretonenkoM.V.KlimstraW.B.RymanK.D.A mouse model for studying viscerotropic disease caused by" exact="yellow fever" post="virus infectionPLoS Pathog.20095e100061410.1371/journal.ppat.100061419816561 107.EricksonA.K.PfeifferJ.K.Dynamic viral dissemination in mice infected"/>
 <result pre="virus infectionPLoS Pathog.20095e100061410.1371/journal.ppat.100061419816561 107.EricksonA.K.PfeifferJ.K.Dynamic viral dissemination in mice infected with" exact="yellow fever" post="virus strain 17DJ. Virol.201387123921239710.1128/JVI.02149-1324027319 108.DhimanG.AbrahamR.GriffinD.E.Human Schwann cells are susceptible"/>
 <result pre="108.DhimanG.AbrahamR.GriffinD.E.Human Schwann cells are susceptible to infection with Zika and" exact="yellow fever" post="viruses, but not dengue virusSci. Rep.20199995110.1038/s41598-019-46389-031289325 109.StuartG.Rections Folowing Vaccination"/>
 <result pre="109.StuartG.Rections Folowing Vaccination against Yellow FeverWorld Health OrganizationGeneva, Switzerland1956 110.BartolK.D.AguirreJ.L.LabruzzoS.V.HenrietR.P.Transverse" exact="myelitis" post="associated with yellow fever vaccinationBayl. Univ. Med Cent. Proc.20193228328510.1080/08998280.2019.1573405"/>
 <result pre="against Yellow FeverWorld Health OrganizationGeneva, Switzerland1956 110.BartolK.D.AguirreJ.L.LabruzzoS.V.HenrietR.P.Transverse myelitis associated with" exact="yellow fever" post="vaccinationBayl. Univ. Med Cent. Proc.20193228328510.1080/08998280.2019.1573405 111.GoldsteinE.J.BellD.J.GunsonR.N.Yellow fever vaccine-associated neurological"/>
 <result pre="at riskBMJ Case Rep.20191210.1136/bcr-2019-22955831088820 112.McMahonA.W.EidexR.B.MarfinA.A.RussellM.SejvarJ.J.MarkoffL.HayesE.B.ChenR.T.BallR.BraunM.M.et al.Neurologic disease associated with 17D-204" exact="yellow fever" post="vaccination: A report of 15 casesVaccine2007251727173410.1016/j.vaccine.2006.11.02717240001 113.TraiberC.Coelho-AmaralP.RitterV.R.WingeA.Infant meningoencephalitis caused"/>
 <result pre="17D-204 yellow fever vaccination: A report of 15 casesVaccine2007251727173410.1016/j.vaccine.2006.11.02717240001 113.TraiberC.Coelho-AmaralP.RitterV.R.WingeA.Infant" exact="meningoencephalitis" post="caused by yellow fever vaccine virus transmitted via breastmilkJ."/>
 <result pre="vaccination: A report of 15 casesVaccine2007251727173410.1016/j.vaccine.2006.11.02717240001 113.TraiberC.Coelho-AmaralP.RitterV.R.WingeA.Infant meningoencephalitis caused by" exact="yellow fever" post="vaccine virus transmitted via breastmilkJ. Pediatr.20118726927210.2223/JPED.206721461453 114.KuhnS.Twele-MontecinosL.MacDonaldJ.WebsterP.LawB.Case report: Probable"/>
 <result pre="breastmilkJ. Pediatr.20118726927210.2223/JPED.206721461453 114.KuhnS.Twele-MontecinosL.MacDonaldJ.WebsterP.LawB.Case report: Probable transmission of vaccine strain of" exact="yellow fever" post="virus to an infant via breast milkCMAJ2011183E243E24510.1503/cmaj.10061921324845 115.collab: Centers"/>
 <result pre="breast milkCMAJ2011183E243E24510.1503/cmaj.10061921324845 115.collab: Centers for Disease Control and PreventionTransmission of" exact="yellow fever" post="vaccine virus through breast-feeding-Brazil, 2009Morb. Mortal. Wkly. Rep.201059130132 116.MonathT.P.VasconcelosP.F.Yellow"/>
 <result pre="116.MonathT.P.VasconcelosP.F.Yellow feverJ. Clin. Virol.20156416017310.1016/j.jcv.2014.08.03025453327 117.GotuzzoE.YactayoS.CordovaE.Efficacy and duration of immunity after" exact="yellow fever" post="vaccination: Systematic review on the need for a booster"/>
 <result pre="Required to Guarantee Protective Immunity in ChildrenFront. Immunol.201910219210.3389/fimmu.2019.0219231616412 120.PatoT.P.SouzaM.C.O.MattosD.A.CarideE.FerreiraD.F.GasparL.P.FreireM.S.CastilhoL.R.Purification of" exact="yellow fever" post="virus produced in Vero cells for inactivated vaccine manufactureVaccine2019373214322010.1016/j.vaccine.2019.04.07731047674"/>
 <result pre="in Vero cells for inactivated vaccine manufactureVaccine2019373214322010.1016/j.vaccine.2019.04.07731047674 121.RoukensA.H.VossenA.C.BredenbeekP.J.van DisselJ.T.VisserL.G.Intradermally administered" exact="yellow fever" post="vaccine at reduced dose induces a protective immune response:"/>
 <result pre="randomized controlled non-inferiority trialPLoS ONE20083e199310.1371/journal.pone.000199318431480 122.RoukensA.H.GelinckL.B.VisserL.G.Intradermal vaccination to protect against" exact="yellow fever" post="and influenzaCurr. Top. Microbiol. Immunol.201235115917910.1007/82_2011_12421416266 123.WatsonA.M.LamL.K.KlimstraW.B.RymanK.D.The 17D-204 Vaccine Strain-Induced"/>
 <result pre="CellsPLoS Pathog.201612e100578610.1371/journal.ppat.100578627463517 124.Perdomo-CelisF.SalvatoM.S.Medina-MorenoS.ZapataJ.C.T-Cell Response to Viral Hemorrhagic FeversVaccines201971110.3390/vaccines701001130678246 125.SouzaM.C.FreireM.S.SchulzeE.A.GasparL.P.CastilhoL.R.Production of" exact="yellow fever" post="virus in microcarrier-based Vero cell culturesVaccine2009276420642310.1016/j.vaccine.2009.06.02319559120 126.MonathT.P.LeeC.K.JulanderJ.G.BrownA.BeasleyD.W.WattsD.M.HaymanE.GuertinP.MakowieckiJ.CrowellJ.et al.Inactivated yellow"/>
 <result pre="yellow fever virus in microcarrier-based Vero cell culturesVaccine2009276420642310.1016/j.vaccine.2009.06.02319559120 126.MonathT.P.LeeC.K.JulanderJ.G.BrownA.BeasleyD.W.WattsD.M.HaymanE.GuertinP.MakowieckiJ.CrowellJ.et al.Inactivated" exact="yellow fever" post="17D vaccine: Development and nonclinical safety, immunogenicity and protective"/>
 <result pre="vaccine: Development and nonclinical safety, immunogenicity and protective activityVaccine2010283827384010.1016/j.vaccine.2010.03.02320347059 127.GasparL.P.MendesY.S.YamamuraA.M.AlmeidaL.F.CarideE.GoncalvesR.B.SilvaJ.L.OliveiraA.C.GallerR.FreireM.S.Pressure-inactivated" exact="yellow fever" post="17DD virus: Implications for vaccine developmentJ. Virol. Methods2008150576210.1016/j.jviromet.2008.03.00218420285 128.PereiraR.C.SilvaA.N.SouzaM.C.SilvaM.V.NevesP.P.SilvaA.A.MatosD.D.HerreraM.A.YamamuraA.M.FreireM.S.et"/>
 <result pre="virus: Implications for vaccine developmentJ. Virol. Methods2008150576210.1016/j.jviromet.2008.03.00218420285 128.PereiraR.C.SilvaA.N.SouzaM.C.SilvaM.V.NevesP.P.SilvaA.A.MatosD.D.HerreraM.A.YamamuraA.M.FreireM.S.et al.An inactivated" exact="yellow fever" post="17DD vaccine cultivated in Vero cell culturesVaccine2015334261426810.1016/j.vaccine.2015.03.07725862300 129.BeasleyD.W.MorinM.LambA.R.HaymanE.WattsD.M.LeeC.K.TrentD.W.MonathT.P.Adaptation of"/>
 <result pre="fever 17DD vaccine cultivated in Vero cell culturesVaccine2015334261426810.1016/j.vaccine.2015.03.07725862300 129.BeasleyD.W.MorinM.LambA.R.HaymanE.WattsD.M.LeeC.K.TrentD.W.MonathT.P.Adaptation of" exact="yellow fever" post="virus 17D to Vero cells is associated with mutations"/>
</results>
